Ray continued, “We’re also delighted to acknowledge Martin and Greg’s contributions to Synthekine with their new roles. Martin’s deep insights into cytokine biology and immunology ended up instrumental to shaping the development of STK-012, our to start with-in-class alpha/beta biased IL-2. Its one of a kind system expands the therapeutic https://https-www-zosanopharma-co87654.ourcodeblog.com/36903938/the-definitive-guide-to-https-www-zosanopharma-com-technology